Fermented Ophiocordyceps sinensis mycelium products for preventing contrast-associated acute kidney injury: a systematic review of randomized controlled trials

References

• McDonald JS, Hunt CH, Kolbe AB, et al. Acute adverse events following gadolinium-based contrast agent administration: a single-center retrospective study of 281 945 injections. Radiology. 2019;292(3):1–14. doi: 10.1148/radiol.2019182834.
   PubMed Web of Science ®Google Scholar
• Morcos R, Kucharik M, Bansal P, et al. Contrast-induced acute kidney injury: review and practical update. Clin Med Insights Cardiol. 2019;13:1179546819878680. doi: 10.1177/1179546819878680.
   Web of Science ®Google Scholar
• Azzalini L, Spagnoli V, Ly HQ. Contrast-induced nephropathy: from pathophysiology to preventive strategies. Can J Cardiol. 2016;32(2):247–255. doi: 10.1016/j.cjca.2015.05.013.
   PubMed Web of Science ®Google Scholar
• Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol. 1999;9(8):1602–1613. doi: 10.1007/s003300050894.
   PubMed Web of Science ®Google Scholar
• Cantais A, Hammouda Z, Mory O, et al. Incidence of contrast-induced acute kidney injury in a pediatric setting: a cohort study. Pediatr Nephrol. 2016;31(8):1355–1362. doi: 10.1007/s00467-016-3313-9.
   PubMed Web of Science ®Google Scholar
• Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19):2259–2264. doi: 10.1161/01.cir.0000016043.87291.33.
   PubMed Web of Science ®Google Scholar
• Rudnick MR, Goldfarb S, Tumlin J. Contrast-induced nephropathy: is the picture any clearer? Clin J Am Soc Nephrol. 2008;3(1):261–262. doi: 10.2215/CJN.04951107.
   PubMed Web of Science ®Google Scholar
• Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996;275(19):1489–1494. doi: 10.1001/jama.1996.03530430033035.
   PubMed Web of Science ®Google Scholar
• Jorgensen AL. Contrast-induced nephropathy: pathophysiology and preventive strategies. Crit Care Nurse. 2013;33(1):37–46. doi: 10.4037/ccn2013680.
   PubMed Web of Science ®Google Scholar
• Rancic ZS. Commentary on ‘Contrast induced nephropathy and long-term renal decline after percutaneous transluminal angioplasty for symptomatic peripheral arterial disease’. Eur J Vasc Endovasc Surg. 2016;51(3):394. doi: 10.1016/j.ejvs.2015.12.013.
   PubMed Web of Science ®Google Scholar
• Cardiology, Group of Interventional. Chinese society of cardiovascular diseases: Chinese guidelines for percutaneous coronary interventions (2016). Chin J Interv Cardiol. 2016;24(6):315.
   Google Scholar
• Hiremath S, Akbari A, Shabana W, et al. Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence. PLOS One. 2013;8(3):e60009. doi: 10.1371/journal.pone.0060009.
   PubMed Web of Science ®Google Scholar
• Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):C179–C184. doi: 10.1159/000339789.
   PubMedGoogle Scholar
• Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines. Eur Radiol. 2011;21(12):2527–2541. doi: 10.1007/s00330-011-2225-0.
   PubMed Web of Science ®Google Scholar
• Nijssen EC, Rennenberg RJ, Nelemans PJ, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017;389(10076):1312–1322. doi: 10.1016/S0140-6736(17)30057-0.
   PubMed Web of Science ®Google Scholar
• Boucek P, Havrdova T, Oliyarnyk O, et al. Prevention of contrast-induced nephropathy in diabetic patients with impaired renal function: a randomized, double blind trial of sodium bicarbonate versus sodium chloride-based hydration. Diabetes Res Clin Pract. 2013;101(3):303–308. doi: 10.1016/j.diabres.2013.05.015.
   PubMed Web of Science ®Google Scholar
• Hoste EA, De Waele JJ, Gevaert SA, et al. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis. Nephrol Dial Transplant. 2010;25(3):747–758. doi: 10.1093/ndt/gfp389.
   PubMed Web of Science ®Google Scholar
• Meier P, Ko DT, Tamura A, et al. Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis. BMC Med. 2009;7(1):23. doi: 10.1186/1741-7015-7-23.
   PubMedGoogle Scholar
• Isaka Y, Hayashi H, Aonuma K, et al. Guideline on the use of iodinated contrast media in patients with kidney disease 2018. Clin Exp Nephrol. 2020;24(1):1–44. doi: 10.1007/s10157-019-01750-5.
   PubMed Web of Science ®Google Scholar
• Orlacchio A, Guastoni C, Beretta GD, et al. SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations-consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM). Radiol Med. 2022;127(5):534–542. doi: 10.1007/s11547-022-01483-8.
   PubMed Web of Science ®Google Scholar
• Bunel V, Qu F, Duez P, et al. Herbal medicines for acute kidney injury: evidence, gaps and frontiers. World J Tradit Chin Med. 2015;1(3):47–66. doi: 10.15806/j.issn.2311-8571.2015.0019.
   Google Scholar
• Anyu AT, Zhang WH, Xu QH. Cultivated cordyceps: a tale of two treasured mushrooms. Chin Med Cult. 2021;4(4):221–227. doi: 10.4103/CMAC.CMAC_41_21.
   Google Scholar
• Gan ZT, Shen C, Yao T. Content characteristics of trace elements in several Chinese wild cordyceps and artificial cordyceps. Int J Pharm Res. 2018;45(6):465–471.
   Google Scholar
• Han RC, Wu HT, Tao HP. 70 years of research and development of Cordyceps sinensis in China. J Appl Entomol. 2019;56(05):849–883.
   Google Scholar
• Ashraf SA, Elkhalifa A, Siddiqui AJ, et al. Cordycepin for health and wellbeing: a potent bioactive metabolite of an entomopathogenic cordyceps medicinal fungus and its nutraceutical and therapeutic potential. Molecules. 2020;25(12):2735. doi: 10.3390/molecules25122735.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang J, Wang W, et al. The chemical constituents and pharmacological actions of Cordyceps sinensis. Evid Based Complement Alternat Med. 2015;2015:575063.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wen C, Duan Y, et al. Advance in Cordyceps militaris (Linn) link polysaccharides: isolation, structure, and bioactivities: a review. Int J Biol Macromol. 2019;132:906–914. doi: 10.1016/j.ijbiomac.2019.04.020.
   PubMed Web of Science ®Google Scholar
• The Business Research Company, Cordyceps sinensis Global Market Report 2023; 2023 [cited 2023 Aug 18]. Available from: https://www.researchandmarkets.com/reports/5783073/cordyceps-sinensis-global-market-report
   Google Scholar
• Bee YO, Zoriah A. Efficacy of Cordyceps sinensis as an adjunctive treatment in hemodialysis patients: a systematic review and meta-analysis. J Tradit Chin Med. 2019;39(1):1–14.
   PubMed Web of Science ®Google Scholar
• Hong T, Zhang M, Fan J. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients. Cochrane Database Syst Rev. 2015;2015(10):CD009698.
   PubMedGoogle Scholar
• Liu W, Gao Y, Zhou Y, et al. Mechanism of Cordyceps sinensis and its extracts in the treatment of diabetic kidney disease: a review. Front Pharmacol. 2022;13:881835. doi: 10.3389/fphar.2022.881835.
   PubMed Web of Science ®Google Scholar
• Zhang HW, Lin ZX, Tung YS, et al. Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database Syst Rev. 2014;2014(12):CD008353.
   PubMedGoogle Scholar
• Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi: 10.1136/bmj.n160.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Savović J, Page MJ, Elbers RG, Sterne JAC. Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane; 2023. Available from www.training.cochrane.org/handbook.
   Google Scholar
• Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–926. doi: 10.1136/bmj.39489.470347.AD.
   PubMed Web of Science ®Google Scholar
• Xu C, Furuya-Kanamori L, Zorzela L, et al. A proposed framework to guide evidence synthesis practice for meta-analysis with zero-events studies. J Clin Epidemiol. 2021;135:70–78. doi: 10.1016/j.jclinepi.2021.02.012.
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Higgins JPT, Altman DG. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane; 2023. Available from www.training.cochrane.org/handbook.
   Google Scholar
• Zhao K, Li YJ, Gao S, et al. Effect of Dongchongxiacao (cordyceps) therapy on contrast-induced nephropathy in patients with type 2 diabetes and renal insufficiency undergoing coronary angiography. J Tradit Chin Med. 2015;35(4):422–427.
   PubMed Web of Science ®Google Scholar
• Zhao K, Li Y, Zhang H. Role of Dongchongxiacao (cordyceps) in prevention of contrast-induced nephropathy in patients with stable angina pectoris. J Tradit Chin Med. 2013;33(3):283–286. doi: 10.1016/s0254-6272(13)60165-x.
   PubMed Web of Science ®Google Scholar
• Zhao K, Lin Y, Li YJ, et al. Efficacy of short-term Cordyceps sinensis for prevention of contrast-induced nephropathy in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention. Int J Clin Exp Med. 2014;7(12):5758–5764.
   PubMed Web of Science ®Google Scholar
• Cao H, Liang G, Jia Y, et al. Clinical study on the prevention of contrast nephropathy after coronary angiography with Jin Shui Bao capsule. Chin Prim Health Care. 2015;29(10):100–101.
   Google Scholar
• Dong J, Mao Y. Effectiveness of Bailing capsules combined with prostil to prevent contrast nephropathy after coronary intervention. Int J Med Health. 2018;24(20):3153–3156.
   Google Scholar
• Li J, Zhu X, Lu Z. Analysis of the effectiveness of Bering capsules combined with prostil to prevent contrast nephropathy after coronary intervention. Inter Med. 2018;13(5):740–743.
   Google Scholar
• Liang G, Luo S, Jia Y, et al. Study on the effect of Jinshuibao capsule intervention in contrast nephropathy. Chin J Integr Chin West Med Emerg Med. 2015;22(4):422–423.
   Google Scholar
• Liao K, Yin W, Ou Q, et al. Study on the prevention of contrast nephropathy with Jinshubao capsules. J Xiangnan Coll (Med Ed). 2011;13(1):28–29.
   Google Scholar
• Shi B. Clinical study of Jinshuibao combined with hydration therapy for the prevention of contrast nephropathy in patients with renal insufficiency. J Guangzhou Med Univ. 2014;42(5):73–76.
   Google Scholar
• Song S. Effect of Jinshuibao capsule combined with prostaglandin on contrast nephropathy after coronary intervention. Pract Drugs Clin. 2017;20(11):1283–1287.
   Google Scholar
• Wang Y, Zhang S, Zheng Y, et al. Prevention of contrast nephropathy after percutaneous coronary intervention in patients with coronary artery disease by combining Renkang injection with Jinshubao capsule. Anhui Med. 2017;21(12):2288–2291.
   Google Scholar
• Xu H. Preventive and protective effects of Bailing capsules on renal damage by contrast agents. Master, Guangzhou University of Chinese Medicine; 2010.
   Google Scholar
• Zhang T, Chen S, Gong Z, et al. Clinical study on the prevention of contrast nephropathy after percutaneous coronary intervention with Jin Shui Bao capsule. Glob Chin Med. 2014;7(9):700–702.
   Google Scholar
• Zhou X. Study on the prevention and treatment of contrast nephropathy by combining kidney protective tablets with Zhi Ling Mycelium capsules. Master, Nanjing University of Traditional Chinese Medicine; 2021.
   Google Scholar
• Lu Q, Li C, Chen W, et al. Clinical efficacy of Jinshuibao capsules combined with angiotensin receptor blockers in patients with early diabetic nephropathy: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2018;2018:6806943. doi: 10.1155/2018/6806943.
   PubMed Web of Science ®Google Scholar
• Luo Y, Yang SK, Zhou X, et al. Use of Ophiocordyceps sinensis (syn. Cordyceps sinensis) combined with angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) versus ACEI/ARB alone in the treatment of diabetic kidney disease: a meta-analysis. Ren Fail. 2015;37(4):614–634. doi: 10.3109/0886022X.2015.1009820.
   PubMed Web of Science ®Google Scholar
• Xu H, Li X, Yuan X, et al. A meta-analysis of the clinical efficacy and safety of Bailing capsules in the treatment of nephrotic syndrome. Ann Palliat Med. 2020;9(5):3170–3181. doi: 10.21037/apm-20-1252.
   PubMed Web of Science ®Google Scholar
• Ong BY, Aziz Z. Efficacy of Cordyceps sinensis as an adjunctive treatment in kidney transplant patients: a systematic-review and meta-analysis. Complement Ther Med. 2017;30:84–92. doi: 10.1016/j.ctim.2016.12.007.
   PubMed Web of Science ®Google Scholar
• Olatunji OJ, Tang J, Tola A, et al. The genus Cordyceps: an extensive review of its traditional uses, phytochemistry and pharmacology. Fitoterapia. 2018;129:293–316. doi: 10.1016/j.fitote.2018.05.010.
   PubMed Web of Science ®Google Scholar
• Qu SL, Li SS, Li D, et al. Metabolites and their bioactivities from the genus Cordyceps. Microorganisms. 2022;10(8):1489. doi: 10.3390/microorganisms10081489.
   PubMed Web of Science ®Google Scholar
• Abedi A, Ghobadi H, Sharghi A, et al. Effect of saffron supplementation on oxidative stress markers (MDA, TAC, TOS, GPx, SOD, and pro-oxidant/antioxidant balance): an updated systematic review and meta-analysis of randomized placebo-controlled trials. Front Med. 2023;10:1071514. doi: 10.3389/fmed.2023.1071514.
   Web of Science ®Google Scholar
• Ali-Hasan-Al-Saegh S, Mirhosseini SJ, Ghodratipour Z, et al. Protective effects of anti-oxidant supplementations on contrast-induced nephropathy after coronary angiography: an updated and comprehensive meta-analysis and systematic review. Kardiol Pol. 2016;74(7):610–626. doi: 10.5603/KP.a2016.0007.
   PubMed Web of Science ®Google Scholar
• Zhang P, Liu W, Zou QW, et al. Research progress on product quality evaluation and control of Cordyceps fermentum type. Chin J Pharm Sci. 2021;56(14):1118–1123.
   Google Scholar
• Zhang H, Li Y, Mi J, et al. GC-MS profiling of volatile components in different fermentation products of Cordyceps sinensis mycelia. Molecules. 2017;22(10):1800. doi: 10.3390/molecules22101800.
   PubMed Web of Science ®Google Scholar